✕
Sunday, April 12, 2026
Breaking
New ‘Liquid Biopsy’ Blood Test Detects Heart Failure Risk Five Years Before Symptoms Develop·Liquid Biopsy Detects 12 Cancer Types From a Single Blood Draw With 89% Accuracy·Statin Use in Adults Over 75 Reduces Heart Attack Risk by 28%, Largest-Ever Meta-Analysis Confirms·New Blood Test Detects Parkinson’s Disease Up to 7 Years Before Symptoms Appear·Wearable ECG Patches Detect Atrial Fibrillation With 94% Accuracy in 30-Day Monitoring Study·New mRNA Vaccine Provides 94% Protection Against All Major Influenza A Subtypes in Phase 3 Trial·WHO Declares H5N1 Bird Flu a Public Health Emergency After Human-to-Human Transmission Confirmed in Three Countries·New ‘Liquid Biopsy’ Blood Test Detects Heart Failure Risk Five Years Before Symptoms Develop·Liquid Biopsy Detects 12 Cancer Types From a Single Blood Draw With 89% Accuracy·Statin Use in Adults Over 75 Reduces Heart Attack Risk by 28%, Largest-Ever Meta-Analysis Confirms·New Blood Test Detects Parkinson’s Disease Up to 7 Years Before Symptoms Appear·Wearable ECG Patches Detect Atrial Fibrillation With 94% Accuracy in 30-Day Monitoring Study·New mRNA Vaccine Provides 94% Protection Against All Major Influenza A Subtypes in Phase 3 Trial·WHO Declares H5N1 Bird Flu a Public Health Emergency After Human-to-Human Transmission Confirmed in Three Countries·
Tag

Vaccines

WHO Declares H5N1 Bird Flu a Public Health Emergency After Human-to-Human Transmission Confirmed in Three CountriesInfectious Disease

WHO Declares H5N1 Bird Flu a Public Health Emergency After Human-to-Human Transmission Confirmed in Three Countries

Dr. Priya NairMar 13, 2026 · 2 min read
mRNA Universal Flu Vaccine Shows 92% Efficacy Across All Influenza Strains in Phase 2 TrialInfectious Disease

mRNA Universal Flu Vaccine Shows 92% Efficacy Across All Influenza Strains in Phase 2 Trial

Dr. Marcus ObiMar 8, 2026 · 2 min read
Pfizer’s RSV Vaccine Provides 89% Protection Against Severe Disease in Adults Over 60 at 3-Year Follow-UpInfectious Disease

Pfizer’s RSV Vaccine Provides 89% Protection Against Severe Disease in Adults Over 60 at 3-Year Follow-Up

James WhitfieldMar 5, 2026 · 2 min read